Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
Van den Eynde
B
B
Ludwig Institute for Cancer Research, Brussels Branch, Belgium.
Gaugler
B
B
van der Bruggen
P
P
Coulie
P
P
Brichard
V
V
Boon
T
T
D000595:Amino Acid Sequence; D000943:Antigens, Differentiation / Q000302:isolation & purification; D000951:Antigens, Neoplasm / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology; D058950:Melanoma-Specific Antigens; D008969:Molecular Sequence Data; D014442:Monophenol Monooxygenase / Q000235:genetics / Q000276:immunology; D005810:Multigene Family; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D009857:Oncogenes; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014407:Tumor Cells, Cultured; D014614:Vaccines, Synthetic / Q000235:genetics / Q000302:isolation & purification*
D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; C072011:MAGEA1 protein, human; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D014614:Vaccines, Synthetic; D014442:Monophenol Monooxygenase